Tag: Prescription Drugs
Stronger Nocebo Effect When Inert Rx Labeled As Expensive
Neural interactions between cortex, brainstem, and spinal cord mediate this effect
Most Cancer Drugs Approved in Europe Show No Survival Benefit
Even in the postmarketing period, half of cancers have no evidence of significant survival gain
Addition of DPP4i to AGI Reduces HbA1c in T2DM
Greater drop in HbA1c with DPP4i added to alpha glucosidase inhibitor, with no increase in weight
Commercialization of Generics Impacts Adverse Event Rates
Adverse events up for generic users of losartan, valsartan, candesartan in month of commercialization
Anticoagulants With Other Drugs Raise Bleeding Risk in AF
And antithrobotic medications linked to higher rate of hematuria-related events in older adults
Sodium-Glucose Cotransporter 2 Inhibitors Not Cancer Risk Factor
Overall cancer risk not increased compared with placebo, other active glucose-lowering treatments
Secukinumab Effective for Moderate/Severe Scalp Psoriasis
Over half of patients have 90 percent improvement on Psoriasis Scalp Severity Index score
About Half of Patients Receive Approval for PCSK9i Prescription
Prescription abandonment linked to copay costs, with rates more than 75 percent for copays > $350
Few Older Patients Aware of Deprescribing
Although the majority surveyed are aware of medication harms
Nonadherence to Statins + ACEIs/ARBs Risky Post MI
Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction
